Harrison is an associate professor in the Department of Ophthalmology and Visual Neurosciences, University of Minnesota in Minneapolis.
e:aharrison@umn.edu
June 30, 2021
FDA approval of teprotumumab as therapeutic offers hope for patients.
Study: Eye doctors receiving even small payments from drug companies more likely to prescribe name-brand eyedrops
Bioengineered cornea can restore sight to the blind and visually impaired
Retina may provide clues to the severity of multiple sclerosis